New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 28, 2014
08:23 EDTMDXGMiMedx still a top pick, says Canaccord
Canaccord reiterated its Buy rating and top pick designation for MiMedx following the company's raised guidance. The firm believes fundamentals are in place to drive execution in wound care for the foreseeable future as the company's increase in sales force remains ahead of plan and reimbursement changes support growth and increased expectations. Canaccord has a $12 price target on the stock.
News For MDXG From The Last 14 Days
Check below for free stories on MDXG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2014
14:28 EDTMDXGOsiris has positive read through from MiMedx results, says Piper Jaffray
Subscribe for More Information
July 28, 2014
16:23 EDTMDXGMiMedx sees operating profit for Q3, consensus 0c
Sees Q3 revenue $30M-$32M, consensus $27.45M.
16:22 EDTMDXGMiMedx raises FY14 revenue view to $110M-$115M from $105M-$110M
Subscribe for More Information
16:21 EDTMDXGMiMedx reports Q2 EPS 0c, consensus 0c
Subscribe for More Information
July 23, 2014
08:02 EDTMDXGMiMedx files its initial investigational New Drug Application
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use